Showing 2,676 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

An interview with Professor Jean-Michel Pawlotsky on how the treatment of HCV infection will change in the near future

Editor's pick
Hepatitis B & C Public Policy Association
17 December 2013
New & experimental hepatitis C treatment

Analysis: Fight for cheap drugs shifts from AIDS to new hepatitis pills

Editor's pick
Reuters
16 December 2013
New & experimental hepatitis C treatment

Why Talk Of A Hepatitis C Price War Should Act As A Warning To The Pharma Industry-At-Large

Editor's pick
Forbes
11 December 2013
New & experimental hepatitis C treatment

Express Scripts Pushes Price Competition for Gilead Drug

Editor's pick
Bloomberg
11 December 2013
New & experimental hepatitis C treatment

AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C

Editor's pick
AbbVie press release
10 December 2013
Pharmaceutical industry

Activists Condemn Gilead for Exorbitant Price of Their New Hepatitis C Drug

Editor's pick
Fair Pricing Coalition / The Body
10 December 2013
New & experimental hepatitis C treatment

Beyond the Hype: What Sofosbuvir Means—and Doesn’t—for Global Hepatitis C Treatment

Editor's pick
Open Society Foundation
10 December 2013
Hepatitis C treatment

EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus

Editor's pick
Eurekalert Inf Dis
9 December 2013
New & experimental hepatitis C treatment

US FDA approves Gilead's $1000-a-day hepatitis C pill

Editor's pick
Reuters
8 December 2013
New & experimental hepatitis C treatment

FDA approves Sovaldi for chronic hepatitis C

Editor's pick
US FDA
8 December 2013
Hepatitis C transmission & prevention

Injection Drug Users Who Know They Have Hepatitis C Practice "Sero-Sharing"

Editor's pick
HIVandhepatitis.com
6 December 2013
New & experimental hepatitis C treatment

Sofosbuvir for Hepatitis C: Simpler, Shorter, Safer?

Editor's pick
Medscape (requires registration)
4 December 2013
Hepatitis B

China's Struggle With Hepatitis B Discrimination

Editor's pick
The Atlantic
4 December 2013
Hepatitis C transmission & prevention

Hepatitis C virus dried on inanimate surfaces can remain infectious for up to six weeks

News
3 December 2013
Pharmaceutical industry

Fair Pricing Coalition Disappointed by the High Price of New Janssen Hepatitis C Drug Olysio (simeprevir)

Editor's pick
Fair Pricing Coalition
29 November 2013
Hepatitis B

Entecavir + tenofovir works well for people with hepatitis B who have had prior treatment failure

News
29 November 2013
Activism & civil society

Ukraininan HIV patients’ organisation is first-ever NGO to get PR award

Editor's pick
Ukrainian Community Advosory Board
28 November 2013
Hepatitis C symptoms & diagnosis

AASLD 2013: Aspirin and Cenicriviroc May Help Reduce Liver Fibrosis

Editor's pick
HIVandhepatitis.com
28 November 2013
New & experimental hepatitis C treatment

Gilead responds over India patent pressure on HCV drug

Editor's pick
PharmaTimes
27 November 2013
New & experimental hepatitis C treatment

Faldaprevir effective across patient sub-groups with several baseline characteristics associated with treatment outcomes

News
27 November 2013
Hepatitis C transmission & prevention

After diagnosis of hepatitis C, some gay men willing to consider risk-reduction practices

News
27 November 2013
New & experimental hepatitis C treatment

Meeting report of the International multi-stakeholders meeting on the compassionate use of HCV treatment

Editor's pick
EATG
26 November 2013
New & experimental hepatitis C treatment

European Medicines Agency advises on compassionate use of daclatasvir

Editor's pick
European Medicines Agency
26 November 2013
Access to healthcare

Indian health activists move to prevent Gilead’s drug patent

Editor's pick
Financial Times
26 November 2013